Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster

[1]  A. Stuckey,et al.  Anxiety trajectories: An observational study of women undergoing chemotherapy for breast or gynecological cancer. , 2022, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[2]  J. Borniger,et al.  Sleep Disruption and Cancer: Chicken or the Egg? , 2022, Frontiers in Neuroscience.

[3]  J. Meyerhardt,et al.  Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Y. Conley,et al.  Associations Between Demographic, Clinical, and Symptom Characteristics and Stress in Oncology Patients Receiving Chemotherapy , 2022, Cancer nursing.

[5]  Shu-Yi Wang,et al.  Cancer-Related Sleep Wake Disturbances. , 2022, Seminars in oncology nursing.

[6]  D. Riemann,et al.  Insomnia and circadian sleep disorders in ovarian cancer: Evaluation and management of underestimated modifiable factors potentially contributing to morbidity , 2021, Journal of sleep research.

[7]  J. Levine,et al.  Stability of Symptom Clusters in Patients With Gynecologic Cancer Receiving Chemotherapy , 2021, Cancer nursing.

[8]  J. Levine,et al.  Distinct sleep disturbance profiles among patients with gynecologic cancer receiving chemotherapy. , 2021, Gynecologic oncology.

[9]  M. Fitch,et al.  Emerging Understanding About the Impact of Financial Toxicity Related to Cancer: Canadian Perspectives. , 2021, Seminars in oncology nursing.

[10]  C. Sandler,et al.  Physical activity and exercise in women with ovarian cancer: A systematic review. , 2020, Gynecologic oncology.

[11]  H. Uno,et al.  Patterns and predictors of cancer‐related fatigue in ovarian and endometrial cancers: 1‐year longitudinal study , 2020, Cancer.

[12]  J. McAlpine,et al.  OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors. , 2019, Gynecologic oncology.

[13]  Linqing Yang,et al.  Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer , 2019, Medicine.

[14]  S. Walters,et al.  Quality of life versus length of life considerations in cancer patients: A systematic literature review , 2019, Psycho-oncology.

[15]  A. Ünlü.  Latent class cluster analysis , 2019, Archives of Psychology.

[16]  J. Nho,et al.  Symptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy. , 2017, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[17]  J. Kutner,et al.  High Symptom Burden and Low Functional Status in the Setting of Multimorbidity , 2017, Journal of the American Geriatrics Society.

[18]  Q. Wen,et al.  Association of financial status and the quality of life in Chinese women with recurrent ovarian cancer , 2017, Health and Quality of Life Outcomes.

[19]  H. Knoop,et al.  Prevalence and impact of severe fatigue in adolescent and young adult cancer patients in comparison with population-based controls , 2017, Supportive Care in Cancer.

[20]  J. Levine,et al.  Distinct evening fatigue profiles in oncology outpatients receiving chemotherapy , 2017, Fatigue : biomedicine, health & behavior.

[21]  Kathryn A. Lee,et al.  Common and Distinct Characteristics Associated With Trajectories of Morning and Evening Energy in Oncology Patients Receiving Chemotherapy. , 2017, Journal of pain and symptom management.

[22]  Deborah Schrag,et al.  Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Kathryn A. Lee,et al.  A Rasch Analysis of Assessments of Morning and Evening Fatigue in Oncology Patients Using the Lee Fatigue Scale. , 2016, Journal of pain and symptom management.

[24]  J. Levine,et al.  Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories , 2016, Supportive Care in Cancer.

[25]  K. Nowicka-Sauer,et al.  Anxiety and depression in patients with advanced ovarian cancer: a prospective study , 2016, Journal of psychosomatic obstetrics and gynaecology.

[26]  H. Donovan,et al.  Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis , 2016, Supportive Care in Cancer.

[27]  E. Bruera,et al.  Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. , 2015, Gynecologic oncology.

[28]  G. Lewith,et al.  Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates , 2015, BMJ Open.

[29]  B. Schmidt,et al.  Predictors and Trajectories of Morning Fatigue Are Distinct From Evening Fatigue. , 2015, Journal of pain and symptom management.

[30]  G. Abrams,et al.  Associations Between Cytokine Genes and a Symptom Cluster of Pain, Fatigue, Sleep Disturbance, and Depression in Patients Prior to Breast Cancer Surgery , 2015, Biological research for nursing.

[31]  Kathryn A. Lee,et al.  Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy , 2014, Cancer.

[32]  S. Garcia,et al.  Physical, emotional, and social health differences between posttreatment young adults with cancer and matched healthy controls , 2014, Cancer.

[33]  J. Chan,et al.  Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care? , 2014, Gynecologic oncology.

[34]  M. Stockler,et al.  Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life. , 2013, Gynecologic oncology.

[35]  Kathryn A. Lee,et al.  Lee Fatigue and Energy Scales: Exploring aspects of validity in a sample of women with HIV using an application of a Rasch model , 2013, Psychiatry Research.

[36]  N. Tarrier,et al.  A longitudinal investigation of posttraumatic stress disorder in patients with ovarian cancer. , 2011, Journal of psychosomatic research.

[37]  David L Ronis,et al.  The Attentional Function Index—a self‐report cognitive measure , 2011, Psycho-oncology.

[38]  Linda M. Collins,et al.  Latent class and latent transition analysis , 2009 .

[39]  A. Brunello,et al.  Dose adjustment and supportive care before and during treatment. , 2009, Cancer treatment reviews.

[40]  D. Pud,et al.  The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. , 2008, Journal of pain and symptom management.

[41]  Kathryn A. Lee,et al.  Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  B. Muthén,et al.  Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study , 2007 .

[43]  Bradley E Aouizerat,et al.  Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. , 2006, Oncology nursing forum.

[44]  D. Ronis,et al.  Pre‐treatment factors related to cognitive functioning in women newly diagnosed with breast cancer , 2005, Psycho-oncology.

[45]  M. Bonetti,et al.  MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. , 2004, European journal of cancer.

[46]  M. Liang,et al.  The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. , 2003, Arthritis and rheumatism.

[47]  B. Muthén,et al.  Finite Mixture Modeling with Mixture Outcomes Using the EM Algorithm , 1999, Biometrics.

[48]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[49]  Katherine R. Edwards,et al.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function , 1995, Pain.

[50]  Kathryn A. Lee,et al.  Self-reported sleep disturbances in employed women. , 1992, Sleep.

[51]  Kathryn A. Lee,et al.  Validity and reliability of a scale to assess fatigue , 1991, Psychiatry Research.

[52]  B. Ferrell,et al.  Defining the content domain of quality of life for cancer patients with pain , 1990, Cancer nursing.

[53]  C. Cleeland,et al.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.

[54]  C Presant,et al.  Quality of life index for patients with cancer. , 1983, Research in nursing & health.

[55]  L. Radloff.  The CES-D Scale , 1977 .

[56]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[57]  Jae Warrander,et al.  Performance of Scale , 2013 .

[58]  D. Correa,et al.  Cognitive function and quality of life in ovarian cancer. , 2012, Gynecologic oncology.

[59]  David Cella,et al.  Quality of life III: translating the science of quality-of-life assessment into clinical practice-an example-driven approach for practicing clinicians and clinical researchers. , 2003, Clinical therapeutics.

[60]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[61]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .